nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—CCBL1—Phenylalanine and tyrosine catabolism—TAT—acquired immunodeficiency syndrome	0.0488	0.417	CbGpPWpGaD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—CSF2—acquired immunodeficiency syndrome	0.00809	0.0692	CbGpPWpGaD
L-Glutamine—TGM2—endothelium—acquired immunodeficiency syndrome	0.00725	0.0183	CbGeAlD
L-Glutamine—GATB—blood plasma—acquired immunodeficiency syndrome	0.00691	0.0174	CbGeAlD
L-Glutamine—TGM6—lung—acquired immunodeficiency syndrome	0.00664	0.0167	CbGeAlD
L-Glutamine—CTPS1—blood plasma—acquired immunodeficiency syndrome	0.00606	0.0153	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—CSF2—acquired immunodeficiency syndrome	0.00546	0.0467	CbGpPWpGaD
L-Glutamine—F13A1—blood plasma—acquired immunodeficiency syndrome	0.00534	0.0135	CbGeAlD
L-Glutamine—TGM5—skin of body—acquired immunodeficiency syndrome	0.00522	0.0132	CbGeAlD
L-Glutamine—SLC38A3—retina—acquired immunodeficiency syndrome	0.0047	0.0118	CbGeAlD
L-Glutamine—CCBL1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00429	0.0367	CbGpPWpGaD
L-Glutamine—GLS2—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00429	0.0367	CbGpPWpGaD
L-Glutamine—GLS—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00429	0.0367	CbGpPWpGaD
L-Glutamine—TGM1—skin of body—acquired immunodeficiency syndrome	0.00422	0.0106	CbGeAlD
L-Glutamine—TGM3—skin of body—acquired immunodeficiency syndrome	0.00396	0.00997	CbGeAlD
L-Glutamine—TGM5—spinal cord—acquired immunodeficiency syndrome	0.00383	0.00966	CbGeAlD
L-Glutamine—CCBL1—retina—acquired immunodeficiency syndrome	0.00378	0.00953	CbGeAlD
L-Glutamine—TGM5—vagina—acquired immunodeficiency syndrome	0.00369	0.00929	CbGeAlD
L-Glutamine—TGM5—lung—acquired immunodeficiency syndrome	0.00349	0.00879	CbGeAlD
L-Glutamine—TGM1—digestive system—acquired immunodeficiency syndrome	0.00338	0.00851	CbGeAlD
L-Glutamine—TGM3—lymphoid tissue—acquired immunodeficiency syndrome	0.0032	0.00807	CbGeAlD
L-Glutamine—TGM3—digestive system—acquired immunodeficiency syndrome	0.00317	0.00797	CbGeAlD
L-Glutamine—TGM2—skin of body—acquired immunodeficiency syndrome	0.00309	0.00779	CbGeAlD
L-Glutamine—TGM3—blood—acquired immunodeficiency syndrome	0.00302	0.0076	CbGeAlD
L-Glutamine—TGM1—vagina—acquired immunodeficiency syndrome	0.00298	0.00751	CbGeAlD
L-Glutamine—NADSYN1—lymphoid tissue—acquired immunodeficiency syndrome	0.00293	0.00738	CbGeAlD
L-Glutamine—GLS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00293	0.00738	CbGeAlD
L-Glutamine—F13A1—retina—acquired immunodeficiency syndrome	0.00292	0.00737	CbGeAlD
L-Glutamine—NADSYN1—digestive system—acquired immunodeficiency syndrome	0.0029	0.00729	CbGeAlD
L-Glutamine—GLS2—digestive system—acquired immunodeficiency syndrome	0.0029	0.00729	CbGeAlD
L-Glutamine—TGM1—lung—acquired immunodeficiency syndrome	0.00282	0.00711	CbGeAlD
L-Glutamine—TGM3—vagina—acquired immunodeficiency syndrome	0.0028	0.00704	CbGeAlD
L-Glutamine—QARS—retina—acquired immunodeficiency syndrome	0.00278	0.007	CbGeAlD
L-Glutamine—GLS2—blood—acquired immunodeficiency syndrome	0.00276	0.00695	CbGeAlD
L-Glutamine—TGM3—lung—acquired immunodeficiency syndrome	0.00264	0.00666	CbGeAlD
L-Glutamine—CAD—retina—acquired immunodeficiency syndrome	0.00256	0.00646	CbGeAlD
L-Glutamine—GLS2—vagina—acquired immunodeficiency syndrome	0.00256	0.00644	CbGeAlD
L-Glutamine—NADSYN1—vagina—acquired immunodeficiency syndrome	0.00256	0.00644	CbGeAlD
L-Glutamine—GLS—lymphoid tissue—acquired immunodeficiency syndrome	0.00253	0.00638	CbGeAlD
L-Glutamine—CCBL1—blood—acquired immunodeficiency syndrome	0.00253	0.00637	CbGeAlD
L-Glutamine—GATB—blood—acquired immunodeficiency syndrome	0.00253	0.00637	CbGeAlD
L-Glutamine—TGM2—lymphoid tissue—acquired immunodeficiency syndrome	0.00251	0.00631	CbGeAlD
L-Glutamine—GLS—digestive system—acquired immunodeficiency syndrome	0.0025	0.0063	CbGeAlD
L-Glutamine—TGM2—digestive system—acquired immunodeficiency syndrome	0.00247	0.00623	CbGeAlD
L-Glutamine—GLUL—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00246	0.0211	CbGpPWpGaD
L-Glutamine—ASNS—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00246	0.0211	CbGpPWpGaD
L-Glutamine—TGM3—nervous system—acquired immunodeficiency syndrome	0.00245	0.00617	CbGeAlD
L-Glutamine—QARS—skin of body—acquired immunodeficiency syndrome	0.00244	0.00615	CbGeAlD
L-Glutamine—CCBL1—spinal cord—acquired immunodeficiency syndrome	0.00244	0.00614	CbGeAlD
L-Glutamine—GLS2—lung—acquired immunodeficiency syndrome	0.00242	0.00609	CbGeAlD
L-Glutamine—NADSYN1—lung—acquired immunodeficiency syndrome	0.00242	0.00609	CbGeAlD
L-Glutamine—GFPT2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00241	0.0206	CbGpPWpGaD
L-Glutamine—GLS—blood—acquired immunodeficiency syndrome	0.00238	0.006	CbGeAlD
L-Glutamine—PPAT—retina—acquired immunodeficiency syndrome	0.00238	0.00599	CbGeAlD
L-Glutamine—GMPS—lymphoid tissue—acquired immunodeficiency syndrome	0.00236	0.00594	CbGeAlD
L-Glutamine—TGM2—blood—acquired immunodeficiency syndrome	0.00236	0.00594	CbGeAlD
L-Glutamine—TGM3—central nervous system—acquired immunodeficiency syndrome	0.00236	0.00594	CbGeAlD
L-Glutamine—GATB—vagina—acquired immunodeficiency syndrome	0.00235	0.00591	CbGeAlD
L-Glutamine—CCBL1—vagina—acquired immunodeficiency syndrome	0.00235	0.00591	CbGeAlD
L-Glutamine—CTPS1—digestive system—acquired immunodeficiency syndrome	0.00233	0.00587	CbGeAlD
L-Glutamine—GMPS—digestive system—acquired immunodeficiency syndrome	0.00233	0.00587	CbGeAlD
L-Glutamine—GFPT2—lymphoid tissue—acquired immunodeficiency syndrome	0.00232	0.00584	CbGeAlD
L-Glutamine—GLS—bone marrow—acquired immunodeficiency syndrome	0.00231	0.00581	CbGeAlD
L-Glutamine—GLS2—nervous system—acquired immunodeficiency syndrome	0.00224	0.00564	CbGeAlD
L-Glutamine—NADSYN1—nervous system—acquired immunodeficiency syndrome	0.00224	0.00564	CbGeAlD
L-Glutamine—CTPS1—blood—acquired immunodeficiency syndrome	0.00222	0.00559	CbGeAlD
L-Glutamine—GMPS—blood—acquired immunodeficiency syndrome	0.00222	0.00559	CbGeAlD
L-Glutamine—GATB—lung—acquired immunodeficiency syndrome	0.00222	0.00559	CbGeAlD
L-Glutamine—CCBL1—lung—acquired immunodeficiency syndrome	0.00222	0.00559	CbGeAlD
L-Glutamine—GLS—vagina—acquired immunodeficiency syndrome	0.00221	0.00557	CbGeAlD
L-Glutamine—GFPT2—blood—acquired immunodeficiency syndrome	0.00218	0.00549	CbGeAlD
L-Glutamine—PFAS—blood—acquired immunodeficiency syndrome	0.00218	0.00549	CbGeAlD
L-Glutamine—NADSYN1—central nervous system—acquired immunodeficiency syndrome	0.00216	0.00543	CbGeAlD
L-Glutamine—GLS2—central nervous system—acquired immunodeficiency syndrome	0.00216	0.00543	CbGeAlD
L-Glutamine—CTPS1—bone marrow—acquired immunodeficiency syndrome	0.00215	0.00541	CbGeAlD
L-Glutamine—GMPS—bone marrow—acquired immunodeficiency syndrome	0.00215	0.00541	CbGeAlD
L-Glutamine—GMPS—spinal cord—acquired immunodeficiency syndrome	0.00214	0.00539	CbGeAlD
L-Glutamine—PFAS—bone marrow—acquired immunodeficiency syndrome	0.00211	0.00531	CbGeAlD
L-Glutamine—GFPT2—spinal cord—acquired immunodeficiency syndrome	0.0021	0.00529	CbGeAlD
L-Glutamine—PFAS—spinal cord—acquired immunodeficiency syndrome	0.0021	0.00529	CbGeAlD
L-Glutamine—GLS—lung—acquired immunodeficiency syndrome	0.00209	0.00526	CbGeAlD
L-Glutamine—F13A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00208	0.00524	CbGeAlD
L-Glutamine—TGM2—lung—acquired immunodeficiency syndrome	0.00207	0.00521	CbGeAlD
L-Glutamine—CTPS1—vagina—acquired immunodeficiency syndrome	0.00206	0.00518	CbGeAlD
L-Glutamine—GMPS—vagina—acquired immunodeficiency syndrome	0.00206	0.00518	CbGeAlD
L-Glutamine—GATB—nervous system—acquired immunodeficiency syndrome	0.00205	0.00518	CbGeAlD
L-Glutamine—CCBL1—nervous system—acquired immunodeficiency syndrome	0.00205	0.00518	CbGeAlD
L-Glutamine—F13A1—digestive system—acquired immunodeficiency syndrome	0.00205	0.00517	CbGeAlD
L-Glutamine—PFAS—vagina—acquired immunodeficiency syndrome	0.00202	0.00509	CbGeAlD
L-Glutamine—GFPT2—vagina—acquired immunodeficiency syndrome	0.00202	0.00509	CbGeAlD
L-Glutamine—CCBL1—central nervous system—acquired immunodeficiency syndrome	0.00198	0.00498	CbGeAlD
L-Glutamine—GATB—central nervous system—acquired immunodeficiency syndrome	0.00198	0.00498	CbGeAlD
L-Glutamine—QARS—lymphoid tissue—acquired immunodeficiency syndrome	0.00198	0.00498	CbGeAlD
L-Glutamine—F13A1—blood—acquired immunodeficiency syndrome	0.00196	0.00493	CbGeAlD
L-Glutamine—SLC38A3—brain—acquired immunodeficiency syndrome	0.00195	0.00492	CbGeAlD
L-Glutamine—QARS—digestive system—acquired immunodeficiency syndrome	0.00195	0.00492	CbGeAlD
L-Glutamine—GMPS—lung—acquired immunodeficiency syndrome	0.00195	0.0049	CbGeAlD
L-Glutamine—CTPS1—lung—acquired immunodeficiency syndrome	0.00195	0.0049	CbGeAlD
L-Glutamine—GLS—nervous system—acquired immunodeficiency syndrome	0.00194	0.00487	CbGeAlD
L-Glutamine—SLC1A5—skin of body—acquired immunodeficiency syndrome	0.00193	0.00487	CbGeAlD
L-Glutamine—TGM1—lymph node—acquired immunodeficiency syndrome	0.00193	0.00486	CbGeAlD
L-Glutamine—TGM2—nervous system—acquired immunodeficiency syndrome	0.00191	0.00482	CbGeAlD
L-Glutamine—GFPT2—lung—acquired immunodeficiency syndrome	0.00191	0.00481	CbGeAlD
L-Glutamine—PFAS—lung—acquired immunodeficiency syndrome	0.00191	0.00481	CbGeAlD
L-Glutamine—F13A1—bone marrow—acquired immunodeficiency syndrome	0.00189	0.00477	CbGeAlD
L-Glutamine—F13A1—spinal cord—acquired immunodeficiency syndrome	0.00188	0.00475	CbGeAlD
L-Glutamine—TGM3—brain—acquired immunodeficiency syndrome	0.00187	0.00471	CbGeAlD
L-Glutamine—GLS—central nervous system—acquired immunodeficiency syndrome	0.00186	0.00469	CbGeAlD
L-Glutamine—QARS—blood—acquired immunodeficiency syndrome	0.00186	0.00468	CbGeAlD
L-Glutamine—TGM2—central nervous system—acquired immunodeficiency syndrome	0.00184	0.00464	CbGeAlD
L-Glutamine—F13A1—vagina—acquired immunodeficiency syndrome	0.00181	0.00457	CbGeAlD
L-Glutamine—CTPS1—nervous system—acquired immunodeficiency syndrome	0.0018	0.00454	CbGeAlD
L-Glutamine—GMPS—nervous system—acquired immunodeficiency syndrome	0.0018	0.00454	CbGeAlD
L-Glutamine—QARS—bone marrow—acquired immunodeficiency syndrome	0.0018	0.00453	CbGeAlD
L-Glutamine—QARS—spinal cord—acquired immunodeficiency syndrome	0.00179	0.00451	CbGeAlD
L-Glutamine—PFAS—nervous system—acquired immunodeficiency syndrome	0.00177	0.00446	CbGeAlD
L-Glutamine—SLC7A8—skin of body—acquired immunodeficiency syndrome	0.00174	0.00438	CbGeAlD
L-Glutamine—CTPS1—central nervous system—acquired immunodeficiency syndrome	0.00174	0.00437	CbGeAlD
L-Glutamine—GMPS—central nervous system—acquired immunodeficiency syndrome	0.00174	0.00437	CbGeAlD
L-Glutamine—QARS—vagina—acquired immunodeficiency syndrome	0.00172	0.00434	CbGeAlD
L-Glutamine—F13A1—lung—acquired immunodeficiency syndrome	0.00172	0.00432	CbGeAlD
L-Glutamine—CAD—blood—acquired immunodeficiency syndrome	0.00172	0.00432	CbGeAlD
L-Glutamine—GLS2—brain—acquired immunodeficiency syndrome	0.00171	0.00431	CbGeAlD
L-Glutamine—NADSYN1—brain—acquired immunodeficiency syndrome	0.00171	0.00431	CbGeAlD
L-Glutamine—PFAS—central nervous system—acquired immunodeficiency syndrome	0.0017	0.00429	CbGeAlD
L-Glutamine—CAD—bone marrow—acquired immunodeficiency syndrome	0.00166	0.00418	CbGeAlD
L-Glutamine—GLS2—lymph node—acquired immunodeficiency syndrome	0.00165	0.00417	CbGeAlD
L-Glutamine—NADSYN1—lymph node—acquired immunodeficiency syndrome	0.00165	0.00417	CbGeAlD
L-Glutamine—CAD—spinal cord—acquired immunodeficiency syndrome	0.00165	0.00416	CbGeAlD
L-Glutamine—QARS—lung—acquired immunodeficiency syndrome	0.00163	0.00411	CbGeAlD
L-Glutamine—PPAT—blood—acquired immunodeficiency syndrome	0.00159	0.00401	CbGeAlD
L-Glutamine—CAD—vagina—acquired immunodeficiency syndrome	0.00159	0.004	CbGeAlD
L-Glutamine—F13A1—nervous system—acquired immunodeficiency syndrome	0.00159	0.004	CbGeAlD
L-Glutamine—GATB—brain—acquired immunodeficiency syndrome	0.00157	0.00396	CbGeAlD
L-Glutamine—CCBL1—brain—acquired immunodeficiency syndrome	0.00157	0.00396	CbGeAlD
L-Glutamine—SLC1A5—lymphoid tissue—acquired immunodeficiency syndrome	0.00156	0.00394	CbGeAlD
L-Glutamine—SLC1A5—digestive system—acquired immunodeficiency syndrome	0.00155	0.00389	CbGeAlD
L-Glutamine—GLUL—retina—acquired immunodeficiency syndrome	0.00154	0.00389	CbGeAlD
L-Glutamine—PPAT—bone marrow—acquired immunodeficiency syndrome	0.00154	0.00388	CbGeAlD
L-Glutamine—PPAT—spinal cord—acquired immunodeficiency syndrome	0.00153	0.00386	CbGeAlD
L-Glutamine—F13A1—central nervous system—acquired immunodeficiency syndrome	0.00153	0.00385	CbGeAlD
L-Glutamine—CCBL1—lymph node—acquired immunodeficiency syndrome	0.00152	0.00382	CbGeAlD
L-Glutamine—GATB—lymph node—acquired immunodeficiency syndrome	0.00152	0.00382	CbGeAlD
L-Glutamine—QARS—nervous system—acquired immunodeficiency syndrome	0.00151	0.0038	CbGeAlD
L-Glutamine—CAD—lung—acquired immunodeficiency syndrome	0.0015	0.00379	CbGeAlD
L-Glutamine—GLS—brain—acquired immunodeficiency syndrome	0.00148	0.00373	CbGeAlD
L-Glutamine—PPAT—vagina—acquired immunodeficiency syndrome	0.00147	0.00371	CbGeAlD
L-Glutamine—SLC1A5—blood—acquired immunodeficiency syndrome	0.00147	0.00371	CbGeAlD
L-Glutamine—TGM2—brain—acquired immunodeficiency syndrome	0.00146	0.00369	CbGeAlD
L-Glutamine—QARS—central nervous system—acquired immunodeficiency syndrome	0.00145	0.00366	CbGeAlD
L-Glutamine—GLS—lymph node—acquired immunodeficiency syndrome	0.00143	0.0036	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—acquired immunodeficiency syndrome	0.00143	0.00359	CbGeAlD
L-Glutamine—SLC1A5—spinal cord—acquired immunodeficiency syndrome	0.00142	0.00357	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.0014	0.012	CbGpPWpGaD
L-Glutamine—PPAT—lung—acquired immunodeficiency syndrome	0.00139	0.00351	CbGeAlD
L-Glutamine—CTPS1—brain—acquired immunodeficiency syndrome	0.00138	0.00347	CbGeAlD
L-Glutamine—GMPS—brain—acquired immunodeficiency syndrome	0.00138	0.00347	CbGeAlD
L-Glutamine—SLC1A5—vagina—acquired immunodeficiency syndrome	0.00137	0.00344	CbGeAlD
L-Glutamine—GLUL—skin of body—acquired immunodeficiency syndrome	0.00135	0.00341	CbGeAlD
L-Glutamine—GFPT2—brain—acquired immunodeficiency syndrome	0.00135	0.00341	CbGeAlD
L-Glutamine—PFAS—brain—acquired immunodeficiency syndrome	0.00135	0.00341	CbGeAlD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.00134	0.0114	CbGpPWpGaD
L-Glutamine—GMPS—lymph node—acquired immunodeficiency syndrome	0.00133	0.00335	CbGeAlD
L-Glutamine—CTPS1—lymph node—acquired immunodeficiency syndrome	0.00133	0.00335	CbGeAlD
L-Glutamine—GFPT2—lymph node—acquired immunodeficiency syndrome	0.00131	0.00329	CbGeAlD
L-Glutamine—PFAS—lymph node—acquired immunodeficiency syndrome	0.00131	0.00329	CbGeAlD
L-Glutamine—ASNS—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.0013	0.0111	CbGpPWpGaD
L-Glutamine—PPAT—nervous system—acquired immunodeficiency syndrome	0.00129	0.00325	CbGeAlD
L-Glutamine—SLC1A5—lung—acquired immunodeficiency syndrome	0.00129	0.00325	CbGeAlD
L-Glutamine—ASNS—blood—acquired immunodeficiency syndrome	0.00126	0.00318	CbGeAlD
L-Glutamine—PPAT—central nervous system—acquired immunodeficiency syndrome	0.00124	0.00313	CbGeAlD
L-Glutamine—SLC7A8—vagina—acquired immunodeficiency syndrome	0.00123	0.0031	CbGeAlD
L-Glutamine—ASNS—bone marrow—acquired immunodeficiency syndrome	0.00122	0.00308	CbGeAlD
L-Glutamine—ASNS—spinal cord—acquired immunodeficiency syndrome	0.00122	0.00307	CbGeAlD
L-Glutamine—F13A1—brain—acquired immunodeficiency syndrome	0.00121	0.00306	CbGeAlD
L-Glutamine—SLC1A5—nervous system—acquired immunodeficiency syndrome	0.0012	0.00301	CbGeAlD
L-Glutamine—F13A1—lymph node—acquired immunodeficiency syndrome	0.00117	0.00295	CbGeAlD
L-Glutamine—ASNS—vagina—acquired immunodeficiency syndrome	0.00117	0.00295	CbGeAlD
L-Glutamine—SLC7A8—lung—acquired immunodeficiency syndrome	0.00116	0.00293	CbGeAlD
L-Glutamine—QARS—brain—acquired immunodeficiency syndrome	0.00115	0.00291	CbGeAlD
L-Glutamine—SLC1A5—central nervous system—acquired immunodeficiency syndrome	0.00115	0.0029	CbGeAlD
L-Glutamine—QARS—lymph node—acquired immunodeficiency syndrome	0.00111	0.00281	CbGeAlD
L-Glutamine—ASNS—lung—acquired immunodeficiency syndrome	0.00111	0.00279	CbGeAlD
L-Glutamine—CTPS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00111	0.00945	CbGpPWpGaD
L-Glutamine—GLUL—lymphoid tissue—acquired immunodeficiency syndrome	0.0011	0.00276	CbGeAlD
L-Glutamine—GLUL—digestive system—acquired immunodeficiency syndrome	0.00108	0.00273	CbGeAlD
L-Glutamine—SLC7A8—nervous system—acquired immunodeficiency syndrome	0.00108	0.00271	CbGeAlD
L-Glutamine—CAD—brain—acquired immunodeficiency syndrome	0.00106	0.00268	CbGeAlD
L-Glutamine—SLC7A8—central nervous system—acquired immunodeficiency syndrome	0.00104	0.00261	CbGeAlD
L-Glutamine—GLUL—blood—acquired immunodeficiency syndrome	0.00103	0.0026	CbGeAlD
L-Glutamine—CAD—lymph node—acquired immunodeficiency syndrome	0.00103	0.00259	CbGeAlD
L-Glutamine—GLUL—bone marrow—acquired immunodeficiency syndrome	0.000998	0.00252	CbGeAlD
L-Glutamine—GLUL—spinal cord—acquired immunodeficiency syndrome	0.000994	0.0025	CbGeAlD
L-Glutamine—PPAT—brain—acquired immunodeficiency syndrome	0.000987	0.00249	CbGeAlD
L-Glutamine—GMPS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000985	0.00842	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000985	0.00842	CbGpPWpGaD
L-Glutamine—GLUL—vagina—acquired immunodeficiency syndrome	0.000957	0.00241	CbGeAlD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000956	0.00817	CbGpPWpGaD
L-Glutamine—PPAT—lymph node—acquired immunodeficiency syndrome	0.000954	0.0024	CbGeAlD
L-Glutamine—CTPS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00094	0.00804	CbGpPWpGaD
L-Glutamine—SLC1A5—brain—acquired immunodeficiency syndrome	0.000914	0.0023	CbGeAlD
L-Glutamine—GLUL—lung—acquired immunodeficiency syndrome	0.000905	0.00228	CbGeAlD
L-Glutamine—NADSYN1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000901	0.0077	CbGpPWpGaD
L-Glutamine—SLC1A5—lymph node—acquired immunodeficiency syndrome	0.000883	0.00222	CbGeAlD
L-Glutamine—QARS—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.000861	0.00736	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.00086	0.00735	CbGpPWpGaD
L-Glutamine—GLUL—nervous system—acquired immunodeficiency syndrome	0.000838	0.00211	CbGeAlD
L-Glutamine—GMPS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000838	0.00716	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000838	0.00716	CbGpPWpGaD
L-Glutamine—SLC16A10—lymphoid tissue—acquired immunodeficiency syndrome	0.000836	0.00211	CbGeAlD
L-Glutamine—Pain—Abacavir—acquired immunodeficiency syndrome	0.000833	0.00171	CcSEcCtD
L-Glutamine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000831	0.00171	CcSEcCtD
L-Glutamine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000824	0.0017	CcSEcCtD
L-Glutamine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000824	0.0017	CcSEcCtD
L-Glutamine—SLC7A8—brain—acquired immunodeficiency syndrome	0.000823	0.00207	CbGeAlD
L-Glutamine—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000822	0.00169	CcSEcCtD
L-Glutamine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000821	0.00169	CcSEcCtD
L-Glutamine—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000819	0.00168	CcSEcCtD
L-Glutamine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000818	0.00168	CcSEcCtD
L-Glutamine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000817	0.00168	CcSEcCtD
L-Glutamine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000816	0.00168	CcSEcCtD
L-Glutamine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000812	0.00167	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000811	0.00167	CcSEcCtD
L-Glutamine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00081	0.00167	CcSEcCtD
L-Glutamine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00081	0.00167	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000809	0.00166	CcSEcCtD
L-Glutamine—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000807	0.00166	CcSEcCtD
L-Glutamine—GLUL—central nervous system—acquired immunodeficiency syndrome	0.000807	0.00203	CbGeAlD
L-Glutamine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000806	0.00166	CcSEcCtD
L-Glutamine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000803	0.00165	CcSEcCtD
L-Glutamine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000799	0.00164	CcSEcCtD
L-Glutamine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000799	0.00164	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000797	0.00164	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—acquired immunodeficiency syndrome	0.000795	0.002	CbGeAlD
L-Glutamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000795	0.00163	CcSEcCtD
L-Glutamine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000793	0.00163	CcSEcCtD
L-Glutamine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000792	0.00163	CcSEcCtD
L-Glutamine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000788	0.00162	CcSEcCtD
L-Glutamine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.00162	CcSEcCtD
L-Glutamine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.00162	CcSEcCtD
L-Glutamine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.00162	CcSEcCtD
L-Glutamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000788	0.00162	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000788	0.00673	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000788	0.00673	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000788	0.00673	CbGpPWpGaD
L-Glutamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000787	0.00162	CcSEcCtD
L-Glutamine—SLC16A10—blood—acquired immunodeficiency syndrome	0.000787	0.00198	CbGeAlD
L-Glutamine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000784	0.00161	CcSEcCtD
L-Glutamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000784	0.00161	CcSEcCtD
L-Glutamine—ASNS—brain—acquired immunodeficiency syndrome	0.000784	0.00197	CbGeAlD
L-Glutamine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000783	0.00161	CcSEcCtD
L-Glutamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000783	0.00161	CcSEcCtD
L-Glutamine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000782	0.00161	CcSEcCtD
L-Glutamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000782	0.00161	CcSEcCtD
L-Glutamine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000778	0.0016	CcSEcCtD
L-Glutamine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000777	0.0016	CcSEcCtD
L-Glutamine—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000777	0.0016	CcSEcCtD
L-Glutamine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000775	0.00159	CcSEcCtD
L-Glutamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000773	0.00159	CcSEcCtD
L-Glutamine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000771	0.00159	CcSEcCtD
L-Glutamine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00077	0.00158	CcSEcCtD
L-Glutamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00077	0.00158	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000766	0.00655	CbGpPWpGaD
L-Glutamine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000762	0.00157	CcSEcCtD
L-Glutamine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00076	0.00156	CcSEcCtD
L-Glutamine—ASNS—lymph node—acquired immunodeficiency syndrome	0.000758	0.00191	CbGeAlD
L-Glutamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000755	0.00155	CcSEcCtD
L-Glutamine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.00155	CcSEcCtD
L-Glutamine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.00155	CcSEcCtD
L-Glutamine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.00155	CcSEcCtD
L-Glutamine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000752	0.00155	CcSEcCtD
L-Glutamine—CCBL1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000752	0.00643	CbGpPWpGaD
L-Glutamine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000745	0.00153	CcSEcCtD
L-Glutamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000742	0.00153	CcSEcCtD
L-Glutamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000741	0.00152	CcSEcCtD
L-Glutamine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000741	0.00152	CcSEcCtD
L-Glutamine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.00152	CcSEcCtD
L-Glutamine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000737	0.00152	CcSEcCtD
L-Glutamine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000735	0.00151	CcSEcCtD
L-Glutamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000735	0.00151	CcSEcCtD
L-Glutamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000735	0.00151	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000731	0.00625	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000731	0.0015	CcSEcCtD
L-Glutamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000731	0.0015	CcSEcCtD
L-Glutamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00073	0.0015	CcSEcCtD
L-Glutamine—SLC16A10—vagina—acquired immunodeficiency syndrome	0.000729	0.00184	CbGeAlD
L-Glutamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000729	0.0015	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000728	0.0015	CcSEcCtD
L-Glutamine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000727	0.0015	CcSEcCtD
L-Glutamine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000725	0.00149	CcSEcCtD
L-Glutamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000724	0.00149	CcSEcCtD
L-Glutamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000723	0.00149	CcSEcCtD
L-Glutamine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000723	0.00149	CcSEcCtD
L-Glutamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000718	0.00148	CcSEcCtD
L-Glutamine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000718	0.00148	CcSEcCtD
L-Glutamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000718	0.00148	CcSEcCtD
L-Glutamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000718	0.00148	CcSEcCtD
L-Glutamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000714	0.00147	CcSEcCtD
L-Glutamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000712	0.00146	CcSEcCtD
L-Glutamine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000711	0.00146	CcSEcCtD
L-Glutamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00071	0.00146	CcSEcCtD
L-Glutamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000708	0.00146	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000703	0.00145	CcSEcCtD
L-Glutamine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000702	0.00144	CcSEcCtD
L-Glutamine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0007	0.00144	CcSEcCtD
L-Glutamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000699	0.00144	CcSEcCtD
L-Glutamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000699	0.00144	CcSEcCtD
L-Glutamine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000698	0.00144	CcSEcCtD
L-Glutamine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.00143	CcSEcCtD
L-Glutamine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.00143	CcSEcCtD
L-Glutamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.00143	CcSEcCtD
L-Glutamine—SLC16A10—lung—acquired immunodeficiency syndrome	0.00069	0.00174	CbGeAlD
L-Glutamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000689	0.00142	CcSEcCtD
L-Glutamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000689	0.00142	CcSEcCtD
L-Glutamine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000689	0.00142	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000688	0.00142	CcSEcCtD
L-Glutamine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000684	0.00141	CcSEcCtD
L-Glutamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000684	0.00141	CcSEcCtD
L-Glutamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000683	0.00141	CcSEcCtD
L-Glutamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000682	0.0014	CcSEcCtD
L-Glutamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00068	0.0014	CcSEcCtD
L-Glutamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00068	0.0014	CcSEcCtD
L-Glutamine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000678	0.0014	CcSEcCtD
L-Glutamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000677	0.00139	CcSEcCtD
L-Glutamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.00138	CcSEcCtD
L-Glutamine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.00138	CcSEcCtD
L-Glutamine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.00138	CcSEcCtD
L-Glutamine—GLS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00067	0.00573	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00067	0.00573	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00067	0.00573	CbGpPWpGaD
L-Glutamine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000668	0.00137	CcSEcCtD
L-Glutamine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000663	0.00136	CcSEcCtD
L-Glutamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000659	0.00136	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000658	0.00135	CcSEcCtD
L-Glutamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.00135	CcSEcCtD
L-Glutamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000656	0.00135	CcSEcCtD
L-Glutamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000654	0.00135	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000654	0.00134	CcSEcCtD
L-Glutamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000654	0.00134	CcSEcCtD
L-Glutamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000651	0.00134	CcSEcCtD
L-Glutamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000651	0.00134	CcSEcCtD
L-Glutamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000646	0.00133	CcSEcCtD
L-Glutamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000646	0.00133	CcSEcCtD
L-Glutamine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000646	0.00133	CcSEcCtD
L-Glutamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000646	0.00133	CcSEcCtD
L-Glutamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000645	0.00133	CcSEcCtD
L-Glutamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000644	0.00133	CcSEcCtD
L-Glutamine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000643	0.00132	CcSEcCtD
L-Glutamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000642	0.00132	CcSEcCtD
L-Glutamine—GLUL—brain—acquired immunodeficiency syndrome	0.00064	0.00161	CbGeAlD
L-Glutamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.00132	CcSEcCtD
L-Glutamine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.00132	CcSEcCtD
L-Glutamine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.00132	CcSEcCtD
L-Glutamine—CCBL1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000639	0.00547	CbGpPWpGaD
L-Glutamine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000639	0.00131	CcSEcCtD
L-Glutamine—CAD—Metabolism—TAT—acquired immunodeficiency syndrome	0.000635	0.00543	CbGpPWpGaD
L-Glutamine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.0013	CcSEcCtD
L-Glutamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000632	0.0013	CcSEcCtD
L-Glutamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000632	0.0013	CcSEcCtD
L-Glutamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000631	0.0013	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00063	0.00538	CbGpPWpGaD
L-Glutamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000629	0.00129	CcSEcCtD
L-Glutamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.00129	CcSEcCtD
L-Glutamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000626	0.00129	CcSEcCtD
L-Glutamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000625	0.00129	CcSEcCtD
L-Glutamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000624	0.00128	CcSEcCtD
L-Glutamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000623	0.00128	CcSEcCtD
L-Glutamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000623	0.00128	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000623	0.00533	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000622	0.00128	CcSEcCtD
L-Glutamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000622	0.00128	CcSEcCtD
L-Glutamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000621	0.00128	CcSEcCtD
L-Glutamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00062	0.00127	CcSEcCtD
L-Glutamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000619	0.00127	CcSEcCtD
L-Glutamine—GLUL—lymph node—acquired immunodeficiency syndrome	0.000619	0.00156	CbGeAlD
L-Glutamine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000618	0.00127	CcSEcCtD
L-Glutamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000618	0.00127	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.00127	CcSEcCtD
L-Glutamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000617	0.00127	CcSEcCtD
L-Glutamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000614	0.00126	CcSEcCtD
L-Glutamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000614	0.00126	CcSEcCtD
L-Glutamine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000614	0.00126	CcSEcCtD
L-Glutamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00061	0.00126	CcSEcCtD
L-Glutamine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00061	0.00125	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000609	0.00125	CcSEcCtD
L-Glutamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000608	0.00125	CcSEcCtD
L-Glutamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000608	0.00125	CcSEcCtD
L-Glutamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000604	0.00124	CcSEcCtD
L-Glutamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00123	CcSEcCtD
L-Glutamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00123	CcSEcCtD
L-Glutamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000596	0.00123	CcSEcCtD
L-Glutamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000593	0.00122	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.00122	CcSEcCtD
L-Glutamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000589	0.00121	CcSEcCtD
L-Glutamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000589	0.00121	CcSEcCtD
L-Glutamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000587	0.00121	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000586	0.00121	CcSEcCtD
L-Glutamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.0012	CcSEcCtD
L-Glutamine—PPAT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000581	0.00496	CbGpPWpGaD
L-Glutamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000579	0.00119	CcSEcCtD
L-Glutamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000576	0.00119	CcSEcCtD
L-Glutamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000574	0.00118	CcSEcCtD
L-Glutamine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000572	0.00118	CcSEcCtD
L-Glutamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000572	0.00118	CcSEcCtD
L-Glutamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.00118	CcSEcCtD
L-Glutamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.00118	CcSEcCtD
L-Glutamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000568	0.00117	CcSEcCtD
L-Glutamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000566	0.00116	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000559	0.00115	CcSEcCtD
L-Glutamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000556	0.00114	CcSEcCtD
L-Glutamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000555	0.00114	CcSEcCtD
L-Glutamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.00114	CcSEcCtD
L-Glutamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000551	0.00113	CcSEcCtD
L-Glutamine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00113	CcSEcCtD
L-Glutamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00055	0.00113	CcSEcCtD
L-Glutamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000547	0.00112	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000546	0.00112	CcSEcCtD
L-Glutamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000542	0.00112	CcSEcCtD
L-Glutamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000542	0.00111	CcSEcCtD
L-Glutamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000542	0.00111	CcSEcCtD
L-Glutamine—CAD—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00054	0.00461	CbGpPWpGaD
L-Glutamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000539	0.00111	CcSEcCtD
L-Glutamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000534	0.0011	CcSEcCtD
L-Glutamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000532	0.0011	CcSEcCtD
L-Glutamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00053	0.00109	CcSEcCtD
L-Glutamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000529	0.00109	CcSEcCtD
L-Glutamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000529	0.00109	CcSEcCtD
L-Glutamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00109	CcSEcCtD
L-Glutamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00109	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.00108	CcSEcCtD
L-Glutamine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000525	0.00108	CcSEcCtD
L-Glutamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000525	0.00108	CcSEcCtD
L-Glutamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000519	0.00107	CcSEcCtD
L-Glutamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000511	0.00105	CcSEcCtD
L-Glutamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000511	0.00105	CcSEcCtD
L-Glutamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00105	CcSEcCtD
L-Glutamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000508	0.00105	CcSEcCtD
L-Glutamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000508	0.00105	CcSEcCtD
L-Glutamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000506	0.00104	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000505	0.00432	CbGpPWpGaD
L-Glutamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000504	0.00104	CcSEcCtD
L-Glutamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000504	0.00104	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.00103	CcSEcCtD
L-Glutamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000501	0.00103	CcSEcCtD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.0005	0.00428	CbGpPWpGaD
L-Glutamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000499	0.00103	CcSEcCtD
L-Glutamine—PPAT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000494	0.00422	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000493	0.00421	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000492	0.00101	CcSEcCtD
L-Glutamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.000998	CcSEcCtD
L-Glutamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.000998	CcSEcCtD
L-Glutamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00048	0.000988	CcSEcCtD
L-Glutamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000479	0.000987	CcSEcCtD
L-Glutamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000478	0.000983	CcSEcCtD
L-Glutamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000476	0.00098	CcSEcCtD
L-Glutamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000476	0.000979	CcSEcCtD
L-Glutamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000475	0.000977	CcSEcCtD
L-Glutamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000474	0.000975	CcSEcCtD
L-Glutamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000473	0.000974	CcSEcCtD
L-Glutamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000473	0.000973	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—acquired immunodeficiency syndrome	0.000472	0.00119	CbGeAlD
L-Glutamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000462	0.00095	CcSEcCtD
L-Glutamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00046	0.000945	CcSEcCtD
L-Glutamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000456	0.000938	CcSEcCtD
L-Glutamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.000937	CcSEcCtD
L-Glutamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000455	0.000936	CcSEcCtD
L-Glutamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000453	0.000931	CcSEcCtD
L-Glutamine—ASNS—Metabolism—TAT—acquired immunodeficiency syndrome	0.000452	0.00387	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TAT—acquired immunodeficiency syndrome	0.000452	0.00387	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000452	0.00093	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000449	0.00384	CbGpPWpGaD
L-Glutamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000449	0.000923	CcSEcCtD
L-Glutamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000442	0.000909	CcSEcCtD
L-Glutamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00044	0.000906	CcSEcCtD
L-Glutamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.000893	CcSEcCtD
L-Glutamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.000883	CcSEcCtD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000425	0.00364	CbGpPWpGaD
L-Glutamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000425	0.000875	CcSEcCtD
L-Glutamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000425	0.000874	CcSEcCtD
L-Glutamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000421	0.000867	CcSEcCtD
L-Glutamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000421	0.000866	CcSEcCtD
L-Glutamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000419	0.000861	CcSEcCtD
L-Glutamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000409	0.000841	CcSEcCtD
L-Glutamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000406	0.000835	CcSEcCtD
L-Glutamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000406	0.000834	CcSEcCtD
L-Glutamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.000834	CcSEcCtD
L-Glutamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000403	0.000829	CcSEcCtD
L-Glutamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.000817	CcSEcCtD
L-Glutamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00039	0.000803	CcSEcCtD
L-Glutamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000387	0.000796	CcSEcCtD
L-Glutamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000387	0.000795	CcSEcCtD
L-Glutamine—GLUL—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000385	0.00329	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000385	0.00329	CbGpPWpGaD
L-Glutamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000384	0.000791	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000384	0.00328	CbGpPWpGaD
L-Glutamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.000786	CcSEcCtD
L-Glutamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00075	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000363	0.0031	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000362	0.00309	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000336	0.00287	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000321	0.00275	CbGpPWpGaD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000314	0.00269	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000283	0.00242	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CCR5—acquired immunodeficiency syndrome	0.000263	0.00225	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00026	0.00223	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000254	0.00217	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CCR5—acquired immunodeficiency syndrome	0.00023	0.00197	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000216	0.00185	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000193	0.00165	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000184	0.00158	CbGpPWpGaD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000182	0.00156	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ALB—acquired immunodeficiency syndrome	0.000172	0.00147	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ALB—acquired immunodeficiency syndrome	0.000172	0.00147	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—acquired immunodeficiency syndrome	0.000165	0.00141	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.00016	0.00136	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000157	0.00134	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00015	0.00128	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—acquired immunodeficiency syndrome	0.000145	0.00124	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000137	0.00117	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000137	0.00117	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ALB—acquired immunodeficiency syndrome	0.000137	0.00117	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALB—acquired immunodeficiency syndrome	0.000111	0.000946	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000101	0.000866	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.26e-05	0.000791	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6—acquired immunodeficiency syndrome	8.94e-05	0.000765	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALB—acquired immunodeficiency syndrome	7.89e-05	0.000674	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALB—acquired immunodeficiency syndrome	7.89e-05	0.000674	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6—acquired immunodeficiency syndrome	7.82e-05	0.000668	CbGpPWpGaD
